Docetaxel
- CAS No.
- 125354-16-7
- Chemical Name:
- Docetaxel
- Synonyms
- Docetaxal;CS-878;DOCETAXOL;PNU 101383;10-Acetyltaxotere;MK-0431 phosphate;10-Acetyldocetaxel;Docetaxel impurity G;ACETYLDOCETAXEL, 10-;Paclitaxel Impurity 3
- CBNumber:
- CB7842087
- Molecular Formula:
- C45H55NO15
- Molecular Weight:
- 849.93
- MDL Number:
- MFCD09028033
- MOL File:
- 125354-16-7.mol
- MSDS File:
- SDS
| Product description | Number | Pack Size | Price |
| 10-acetyl Docetaxel ≥98% | 34497 | 50mg | $119 |
| 10-acetyl Docetaxel ≥98% | 34497 | 100mg | $225 |
| Docetaxal | TRC-D494565-50MG | 50mg | $220 |
| Docetaxal | TRC-D494565-25MG | 25mg | $133 |
| Docetaxal | TRC-D494565-100MG | 100mg | $378 |
| More product size | |||
| Melting point | 201-203 °C(Solv: methanol (67-56-1)) |
|---|---|
| Boiling point | 901.4±65.0 °C(Predicted) |
| Density | 1.36±0.1 g/cm3(Predicted) |
| storage temp. | 2-8°C |
| solubility | Chloroform (Slightly), Methanol (Slightly) |
| form | Solid |
| pka | 11.20±0.46(Predicted) |
| color | White to Off-White |
| Major Application | pharmaceutical small molecule |
| UNSPSC Code | 41116107 |
| NACRES | NA.24 |
SAFETY
Risk and Safety Statements
| Symbol(GHS) | ![]() ![]() GHS08,GHS07 |
|---|---|
| Signal word | Danger |
| Hazard statements | H319-H341-H360D-H362 |
| Precautionary statements | P202-P260-P263-P264-P305+P351+P338-P308+P313 |
| WGK Germany | WGK 3 |
| Storage Class | 6.1C - Combustible acute toxic Cat.3 toxic compounds or compounds which causing chronic effects |
| Hazard Classifications | Eye Irrit. 2 Lact. Muta. 2 Repr. 1B |
Docetaxel price More Price(50)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Cayman Chemical | 34497 | 10-acetyl Docetaxel ≥98% | 125354-16-7 | 50mg | $119 | 2026-04-30 | Buy |
| Cayman Chemical | 34497 | 10-acetyl Docetaxel ≥98% | 125354-16-7 | 100mg | $225 | 2026-04-30 | Buy |
| TRC | TRC-D494565-50MG | Docetaxal | 125354-16-7 | 50mg | $220 | 2026-06-03 | Buy |
| TRC | TRC-D494565-25MG | Docetaxal | 125354-16-7 | 25mg | $133 | 2026-06-03 | Buy |
| TRC | TRC-D494565-100MG | Docetaxal | 125354-16-7 | 100mg | $378 | 2026-06-03 | Buy |
Docetaxel Chemical Properties,Uses,Production
Uses
Docetaxal is an impurity of Docetaxel (D494420), a semisynthetic derivative of Paclitaxel (P132500). Docetaxel is an antimitotic agent that promotes the assembly of micro-tubules and inhibits their de -polymerization to free tubulin.
Uses
Docetaxal (Docetaxel EP Impurity G) is an impurity of Docetaxel (D494420), a semisynthetic derivative of Paclitaxel (P132500). Docetaxel is an antimitotic agent that promotes the assembly of micro-tubules and inhibits their de-polymerization to free tubulin.
General Description
Docetaxel is available in single-dose vials of 20 mg/0.5 mLand 80 mg/2 mL for IV administration in the treatment of breast, NSCLC, and prostate cancers. It has also been utilizedin non–FDA-approved treatment of head, neck, gastric,bladder, and refractory ovarian cancers.
Docetaxel is highly plasma protein bound (80%) andwidely distributed with the highest concentration in the hepatobiliarysystem, but it does not appear to cross the bloodbrainbarrier. The metabolism of docetaxel has been lesswell studied than that of paclitaxel. The use of human livermicrosomes has indicated that metabolism involves oxidationof one of the tert-butyl methyl groups of the C-13 sidechain to initially give the alcohol. Further oxidation to thealdehyde and carboxylic acid both of which may cyclizewith the carbamate nitrogen to give stereoisomeric hydroxyoxazolidinonesand an oxazolidinedione, respectively. Noactive metabolites have been identified. The major enzymeinvolved is CYP3A4. The drug is primarily eliminated in thefeces with a terminal half-life of 11 hours.
The adverse effects profile for docetaxel is similar to thatof paclitaxel but also includes reversible fluid retention that isdose related. This has been associated with an initial increasein capillary permeability followed by a decrease in lymphaticdrainage later in the therapy. Restriction of sodium intake andpretreatment with corticosteroids is usually successful inminimizing this adverse effect. Peripheral neuropathy is seenwith docetaxel but occurs less often than with paclitaxel.Fatigue and muscle pain are commonly seen, and fever mayoccur in up to 30% of patients who are infection free.
Docetaxel Preparation Products And Raw materials
Raw materials
Preparation Products
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Henan Tianfu Chemical Co.,Ltd. | +86-0371-55170693 +86-19937530512 | info@tianfuchem.com | China | 21587 | 55 |
| Nanjing ChemLin Chemical Industry Co., Ltd. | 025-83697070 | product@chemlin.com.cn | CHINA | 3009 | 60 |
| Nanjing Finetech Chemical Co., Ltd. | 025-85710122 17714198479 | sales@fine-chemtech.com | CHINA | 885 | 55 |
| career henan chemical co | +86-0371-86658258 +8613203830695 | sales@coreychem.com | China | 29815 | 58 |
| Shenzhen Nexconn Pharmatechs Ltd | +86-755-89396905 +86-15013857715 | admin@nexconn.com | China | 10403 | 58 |
| Standardpharm Co. Ltd. | 86-714-3992388 | overseasales1@yongstandards.com | United States | 14332 | 58 |
| BOC Sciences | +1-631-485-4226 | inquiry@bocsci.com | United States | 19936 | 58 |
| TargetMol Chemicals Inc. | +1-781-999-5354; +17819995354 | marketing@targetmol.com | United States | 32466 | 58 |
| ANHUI WITOP BIOTECH CO., LTD | +8615255079626 | eric@witopchemical.com | China | 23541 | 58 |
| Dideu Industries Group Limited | +86-29-89586680 +86-15129568250 | 1026@dideu.com | China | 20582 | 58 |
Related articles
- Common side effects of Docetaxel
- Docetaxel is a chemotherapy drug. It is used to treat many types of cancer including breast, prostate, stomach, head and neck,....
- Aug 20,2019
View Lastest Price from Docetaxel manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
![]() |
2026-05-11 | Docetaxal
125354-16-7
|
$39.00-113.00 | 10g | TargetMol Chemicals Inc. | |||
![]() |
2025-11-18 | Docetaxel USP/EP/BP
125354-16-7
|
$1.10 | 1g | 99.9% | 100 Tons Min | Dideu Industries Group Limited | |
![]() |
2020-05-03 | Docetaxel
125354-16-7
|
1KG | 99.0% | 800 ton | Shaanxi Dideu Medichem Co. Ltd |
-

- Docetaxal
125354-16-7
- $39.00-113.00
- TargetMol Chemicals Inc.
-

- Docetaxel USP/EP/BP
125354-16-7
- $1.10
- 99.9%
- Dideu Industries Group Limited
-

- Docetaxel
125354-16-7
- 99.0%
- Shaanxi Dideu Medichem Co. Ltd
125354-16-7(Docetaxel)Related Search:
1of4






